Home > Quotes > MYL > Company News
MYL

Mylan Inc. News Headlines

$31.17
*  
0.11
  negative  
0.35%
Get MYL Alerts
*Delayed - data as of May 21, 2013 10:03 ET 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
View:    MYL Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Mylan Says FDA Accepts ANDA For Acyclovir Ointment - Quick Facts
4/3/2013 3:20:00 PM - RTT News

KaloBios Pharma Incurs Wider Loss - Analyst Blog
4/3/2013 1:22:08 PM - Zacks.com

Perrigo Touches 52-Week High - Analyst Blog
4/3/2013 9:23:05 AM - Zacks.com

Perrigo Buys Velcera - Analyst Blog
4/2/2013 5:24:35 PM - Zacks.com

Dr. Reddy's Launches Generic Accutane - Analyst Blog
4/1/2013 5:11:48 PM - Zacks.com

Actavis/AZN Settle Crestor Litigation - Analyst Blog
3/26/2013 4:24:45 PM - Zacks.com

Data on Teva's Azilect - Analyst Blog
3/25/2013 7:26:35 PM - Zacks.com

Back to Neutral on Warner Chilcott - Analyst Blog
3/21/2013 2:32:22 PM - Zacks.com

Good News for Mylan's Generic Unit - Analyst Blog
3/20/2013 1:46:54 PM - Zacks.com

Mylan Launches Generic Version Of Xopenex Inhalation Solution
3/18/2013 11:37:00 AM - RTT News

Mylan Settles Patent Dispute - Analyst Blog
3/14/2013 2:13:18 PM - Zacks.com

Mylan Settles Fortamet Patent Suit
3/13/2013 3:43:00 PM - RTT News

Actavis in Patent Challenge - Analyst Blog
3/11/2013 5:12:02 PM - Zacks.com

Teva Enrolls Patients in MS Study - Analyst Blog
3/8/2013 4:50:01 PM - Zacks.com

EU Approves Roche's Perjeta - Analyst Blog
3/7/2013 1:10:01 PM - Zacks.com

This Little-Known Stock Could Double Thanks To The 'Patent Cliff'
3/6/2013 7:39:00 PM - Seeking Alpha

Setback for Impax, Shares Plunge - Analyst Blog
3/6/2013 6:55:01 PM - Zacks.com

Patent Relief for Pfizer - Analyst Blog
3/6/2013 5:15:01 PM - Zacks.com

Good News for Pernix Therapeutics - Analyst Blog
3/5/2013 5:55:06 PM - Zacks.com

Actavis Files ANDA for Endo Product - Analyst Blog
3/5/2013 5:40:01 PM - Zacks.com

Dr. Reddy's Launches Generic Zometa - Analyst Blog
3/5/2013 4:40:01 PM - Zacks.com

UPDATE: Pfizer Gets Reissued Celebrex Patent, Extends Exclusivity
3/5/2013 12:43:00 PM - Dow Jones Business News

Pfizer Get Reissued Patent for Celebrex
3/5/2013 10:25:00 AM - Dow Jones Business News

Pfizer Get Reissued Patent for Celebrex; Extends Exclusivity to 2015
3/5/2013 10:11:00 AM - Dow Jones Business News

FDA Approves Actavis Generic - Analyst Blog
3/1/2013 1:10:01 PM - Zacks.com